A diabetic patient presents with fungal infection of sinuses and peri-orbital region with significant visual impairment. The best drug for treatment of this patient is:
Wait, fungal sinusitis can be either non-invasive or invasive. Invasive fungal sinusitis is more common in immunocompromised patients like diabetics. The most common culprit here is probably Mucor or other Zygomycetes. That's called mucormycosis. Oh right, rhino-orbital-cerebral mucormycosis is a serious condition in diabetics, especially those with ketoacidosis.
So the treatment for mucormycosis usually involves antifungal medications and surgical debridement. The drug of choice for mucormycosis is amphotericin B. Let me confirm. Yes, amphotericin B is the first-line treatment because it's effective against Zygomycetes. Other antifungals like voriconazole or itraconazole might not work as well here.
Now, looking at the options (even though the options A-D aren't listed here), the correct answer would be amphotericin B. The other options might include drugs like fluconazole, which is used for Candida or Cryptococcus, but not for mucormycosis. Terbinafine might be for dermatophytes. Itraconazole is for aspergillosis. So those would be incorrect here.
The clinical pearl here is that in a diabetic with rhino-orbital symptoms and visual loss, think mucormycosis and start amphotericin immediately. Also, control blood sugar is crucial. Time is critical because the infection can spread rapidly to the brain.
**Core Concept**
This question tests knowledge of fungal infections in immunocompromised patients, specifically *mucormycosis* (Zygomycosis) in diabetics. The infection involves the paranasal sinuses, orbit, and may progress to the central nervous system, requiring rapid antifungal therapy.
**Why the Correct Answer is Right**
The clinical presentation of sinus and orbital fungal infection with visual impairment in a diabetic patient is classic for **rhino-orbital mucormycosis**. The drug of choice is **amphotericin B**, a polyene antifungal that binds to ergosterol in fungal cell membranes, causing leakage and cell death. It is effective against Zygomycetes, the causative organisms, and must be administered intravenously. Early treatment is critical to prevent rapid spread to the brain.
**Why Each Wrong Option is Incorrect**
**Option A:** *Fluconazole* is a triazole antifungal effective against *Candida* and *Cryptococcus* but not Zygomycetes.
**Option B:** *Terbinafine* is an allylamine antifungal targeting dermatophytes, ineffective for mucormycosis.
**Option C:** *Itraconazole* is another triazole with activity against *Aspergillus* but poor efficacy against Zygomycetes.
**Clinical Pearl / High-Yield Fact**
**Diabetic ketoacidosis** is the most common predisposing factor for muc